Charles Semba

Charles Semba

Direktor/Vorstandsmitglied bei DIAMEDICA THERAPEUTICS INC.

Vermögen: 200 857 $ am 31.05.2024

64 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Charles Semba

EinheitArt der EinheitIndustrie
Stanford University
318
College/University Other Consumer Services 318
63
Non-Profit Organization Medical/Nursing Services 63
60
Non-Profit Organization Miscellaneous Commercial Services 60
Public Company Pharmaceuticals: Major 16
Extinct Pharmaceuticals: Major 8
3
Subsidiary Electronic Equipment/Instruments 3
1
Private Company Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Charles Semba

UnternehmenSektorVerknüpfte PersonenHauptposition
CHIQUITA BRANDS INTERNATIONAL INC Agricultural Commodities/Milling

Roderick M. Hills

Jaime José Serra Puche

Director/Board Member

Director/Board Member

CISCO SYSTEMS, INC. Telecommunications Equipment

Jerry Yang

John Morgridge

Director/Board Member

Chairman

Biotechnology

Jeffrey L. Cleland

Marc Tessier-Lavigne

Amy Burroughs

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Tanya Lewis

James Topper

General Counsel

Chief Tech/Sci/R&D Officer

MORGAN STANLEY Investment Managers

Henry Fernandez

Ali Ojjeh

Ruth Porat

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

Internet Software/Services

Ruth Porat

Arun Majumdar

President

Corporate Officer/Principal

Board of Trustees of the Leland Stanford Junior University Regional Banks

Albert Dien

Kelly Beals

Rosa Gonzalez

Scott Jahnke

Amy Paulsen

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Sandra Ballinghoff

Richard Douglas Rivers

Masters Business Admin

Undergraduate Degree

Dartmouth College College/University

Rob Morris

Catherine Zoi

Drew Endy

Amy Burroughs

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Richard Pilnik

Catherine Zoi

Undergraduate Degree

Undergraduate Degree

College/University

Jonathan Lim

Richard Douglas Rivers

Emil M. deGoma

Michael Genesereth

Michael Camuñez

Amy Zegart

Michael Fischbach

Robert Negrin

Graduate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

College/University

Robert L. Joss

Susan M. Welsh

Matthew Klein

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

University of Pennsylvania College/University

Matthew Klein

Chris Gerdes

Undergraduate Degree

Undergraduate Degree

Board of Trustees of Stanford University

Albert Dien

Kelly Beals

Scott Jahnke

Amy Paulsen

Sheila Sanchez

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Robert Foley

Marc Lipschultz

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Terrence O. Hughes

Mark Stevens

Undergraduate Degree

Director/Board Member

McGill University College/University

Jonathan Lim

Marc Tessier-Lavigne

Doctorate Degree

Undergraduate Degree

University of California, Los Angeles College/University

Ken E. Drazan

Jeffrey H. Kleck

Corporate Officer/Principal

Doctorate Degree

Investment Managers

Susan J. Knox

John I. Brauman

Paul Yock

Consultant / Advisor

Director/Board Member

Director/Board Member

Massachusetts Institute of Technology College/University

Bradford W. Parkinson

Myron Samuel Scholes

Jeffrey L. Cleland

Drew Endy

Michael Genesereth

Jennifer Cochran

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

The University of Chicago College/University

Myron Samuel Scholes

Thomas Quertermous

Corporate Officer/Principal

Doctorate Degree

Yale University College/University

Ken E. Drazan

Jaime José Serra Puche

Matthew Klein

Undergraduate Degree

Director/Board Member

Doctorate Degree

New York University College/University

Steven Oyer

Jaime José Serra Puche

Corporate Officer/Principal

Corporate Officer/Principal

Princeton University College/University

John Harold Scully

Paul Koontz

Henry Fernandez

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Santa Clara University College/University

Peter Fitzgerald

Hector Casab

Undergraduate Degree

Masters Business Admin

University of Wisconsin College/University

John Morgridge

Thomas Krummel

Undergraduate Degree

Undergraduate Degree

University of California, Berkeley College/University

Richard L. Sandor

Susan M. Welsh

Susan J. Knox

Arun Majumdar

Chris Gerdes

Robert Negrin

Vanila Singh

Corporate Officer/Principal

Masters Business Admin

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

University of California, Davis College/University

Jeffrey L. Cleland

Susan J. Knox

Undergraduate Degree

Doctorate Degree

College/University

Richard L. Sandor

David Wambeke

Doctorate Degree

Undergraduate Degree

The University of California, San Francisco College/University

Marc Tessier-Lavigne

Michael Fischbach

Corporate Officer/Principal

Corporate Officer/Principal

Hospital/Nursing Management

Henry Fernandez

Ruth Porat

Director/Board Member

Director/Board Member

Investment Trusts/Mutual Funds

Ruth Porat

Amy Zegart

Director/Board Member

Corporate Officer/Principal

Hospital/Nursing Management

John Harold Scully

John Morgridge

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

John I. Brauman

Marc Tessier-Lavigne

Corporate Secretary

Corporate Officer/Principal

The Hoover Institution

Joel Peterson

Myron Samuel Scholes

Henry Fernandez

Chairman

Corporate Officer/Principal

Director/Board Member

Biotechnology

Julie VanOrsdel Daves

Corporate Officer/Principal

Browning School, Inc.

Henry Fernandez

Director/Board Member

Miscellaneous Commercial Services

John Morgridge

Thomas Krummel

Director/Board Member

Director/Board Member

University of California College/University

Robert Calfee

Douglas Blayney

Corporate Officer/Principal

Undergraduate Degree

Harvard Business School College/University

Mark Stevens

Marc Lipschultz

Joel Peterson

Amy Burroughs

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Stanford Graduate School of Business College/University

Chuck Schwab

Henry Fernandez

Ali Ojjeh

Masters Business Admin

Masters Business Admin

Masters Business Admin

The Wharton School of the University of Pennsylvania College/University

Robert Foley

Ruth Porat

Antonio Oporto del Olmo

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Stanford University School of Medicine College/University

Peter Fitzgerald

James Topper

Thomas Krummel

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

EXICURE, INC. Biotechnology

Jeffrey L. Cleland

Emil M. deGoma

Director/Board Member

Chief Tech/Sci/R&D Officer

Investment Managers

Thomas Krummel

Jennifer Cochran

Private Equity Investor

Chief Tech/Sci/R&D Officer

George Washington University School of Medicine & Health College/University

Vanila Singh

Julie VanOrsdel Daves

Doctorate Degree

Graduate Degree

Catalog/Specialty Distribution

John Howard

Corporate Officer/Principal

ROYALTY PHARMA PLC Pharmaceuticals: Major

Henry Fernandez

Director/Board Member

Statistik

International

Vereinigte Staaten 48
Kanada 2
Spanien 2

Sektoral

Consumer Services 26
Finance 7
Health Technology 6
Technology Services 3
Health Services 3

Operativ

Director/Board Member 563
Corporate Officer/Principal 280
Founder 113
Chairman 107
Independent Dir/Board Member 97
  1. Börse
  2. Insiders
  3. Charles Semba
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT